Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -234.45 |
| peg ratio | 1.78 |
| price to book ratio | 276.53 |
| price to sales ratio | 690.02 |
| enterprise value multiple | -37.96 |
| price fair value | 276.53 |
profitability ratios | |
|---|---|
| gross profit margin | 80.41% |
| operating profit margin | -2370.63% |
| pretax profit margin | -2352.52% |
| net profit margin | -2344.75% |
| return on assets | -40.31% |
| return on equity | -79.64% |
| return on capital employed | -43.97% |
liquidity ratio | |
|---|---|
| current ratio | 13.03 |
| quick ratio | 12.88 |
| cash ratio | 12.02 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 1,224.75 |
| operating cycle | 1,919.32 |
| days of payables outstanding | 1,938.87 |
| cash conversion cycle | -19.56 |
| receivables turnover | 0.53 |
| payables turnover | 0.19 |
| inventory turnover | 0.30 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.32 |
| debt equity ratio | 0.94 |
| long term debt to capitalization | 0.48 |
| total debt to capitalization | 0.48 |
| interest coverage | -11.23 |
| cash flow to debt ratio | -0.85 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.16 |
| cash per share | 0.52 |
| operating cash flow per share | -0.16 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.85 |
| short term coverage ratios | -109.02 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
Verona Pharma plc (VRNA) published its most recent earnings results on 04-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Verona Pharma plc (NASDAQ:VRNA)'s trailing twelve months ROE is -79.64%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Verona Pharma plc (VRNA) currently has a ROA of -40.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
VRNA reported a profit margin of -2344.75% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 13.03 in the most recent quarter. The quick ratio stood at 12.88, with a Debt/Eq ratio of 0.94.